Search database
LIST OPTIONS
Filter
102
Filtered Results: 102
Text search: heterologous
Featured
Language
Document type
Guidelines
40
No document type
32
Studies & Reports
13
Manuals
5
Fact sheets
5
Strategic & Response Plan
4
Situation Updates
2
Infographics
1
Countries / Regions
Brazil
8
India
6
Argentina
5
Africa
3
Latin America and the Carribbean
3
South Africa
3
Nigeria
2
Mozambique
2
Paraguay
2
Bolivia
2
Russia
2
Chile
1
Philippines
1
Global
1
Asia
1
Tanzania
1
Germany
1
East and Southern Africa
1
Uganda
1
Indonesia
1
Ecuador
1
Authors & Publishers
World Health Organization WHO
35
Ministerio de Salud Argentina
4
OPAS
4
World Health Organization
4
Abela-Ridder, B.
2
Dirección de Control de Enfermedades Inmunoprevenibles
2
Federal Ministry of Health, Nigeria
2
Feraud, H.
2
Indian Council of Medical Research
2
Organisation Mondiale de la Santé OMS
2
Organización Mundial de la Salud OMS
2
Organización Mundial de Saude and OPAS
2
Organização Mundial da Saúde (OMS)
2
Rupprecht, C.
2
WHO
2
World Health Organisation (WHO)
2
World Health Organization (WHO)
2
World Heart Federation
2
Abubakar, B.K.
1
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
Ahmad, U., Chau, D.M. et al.
1
Bill & Melinda Gates Foundation
1
BioMed Central
1
BMC Part of Springer Nature
1
BooMed Central
1
Dept. of Health South Africa
1
Dra. María Cristina San Miguel de Vera
1
E. Malchiodi, J.P. Ioset, et al.
1
Elsevier Ltd.
1
Erwinanto, A. Santoso, J. N. E. Putranto, et al.,
1
Fairlamb, A.H.
1
Ference, B.A.
1
Fooks, A,
1
Fooks, A.
1
Garratt, A.
1
Gavi, the Vaccine Alliance
1
Gerald Keusch, Keith McAdam, Patricia Cuff, Michelle Mancher, and Emily R. Busta
1
Guo, J.
1
HelpAge
1
Hill, A.
1
Hindawi Publishing Corporation
1
Horn, D.
1
IACAPAP
1
Ibarra-Cerdena, C.
1
Indonesian Heart Association
1
Izeta-Alberdi, A.
1
J. A. Triccas, C. Counoupas
1
J. J. C. Nuttal, B. S. Eley
1
Jara A., Undurraga E. A. et al
1
JCI insight
1
Journal of Cystic Fibrosis
1
Journal of Movements Disorders
1
Logunov, D.Y, et al.
1
M. A. Gasper, A. C. Hesseling, I. Mohar, et al.
1
Ministerio da Saude Brasilia
1
Ministerio de Salud
1
Ministerio de Salud Bolivia
1
Ministerio de Salud Pública de Ecuador
1
Ministerio de Salud Pública, Paraguay
1
Ministerio de Salud, Argentina
1
Ministério da Saúde, Brasil
1
Ministry of Health & Family Welfare India
1
Moo-llanes, D.
1
Muntean Al., Popa M.
1
National Academies of Sciences, Engineering, and Medicine
1
National Centre for Disease Control
1
National Department of Health, South Africa
1
National Health Mission (NHM), Ministry of Health & Family Welfare, Government of India
1
National Institue of communicable Diseases, India
1
National Rabies Programme
1
O. Bandmann
1
OPAS, OMS
1
OPS
1
Organización Panamericana de la Salud
1
Pan American Health Organisation PAHO
1
Pan American Health Organization PAHO
1
Pinazo, M.J.
1
Pneumonia
1
Popa G.
1
R. R. Althoff
1
R. Walker
1
Ramsey,J.
1
Ray, K.K.
1
RCC Service
1
Saudi Journal of Biological Sciences
1
Secretaria Extraordinária de Enfrentamento à COVID-19, Brasil
1
Séverin, T. et al.
1
TDR
1
Trials
1
U. Williams
1
UNICEF
1
V. Nankabirwa , J. K. Tumwine, O. Namugga, et al.
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
World Health Organization WHO, Regional Office of Africa
1
World Health Organization WHO, SAGE
1
World Health Organization, Regional Office for the Americas
1
Publication Years
Category
Countries
34
Clinical Guidelines
11
Public Health
4
Pharmacy & Technologies
3
Capacity Building
1
Women & Child Health
1
Toolboxes
COVID-19
48
NTDs
8
Rapid Response
5
TB
4
NCDs
3
Mental Health
2
Zika
2
Ebola & Marburg
1
Planetary Health
1
Pharmacy
1
Health Financing Toolbox
1
Polio
1
Global Health Education
1
 Download  (266)
  View PDF  (154)
 Add to my MEDBOX

Manual del Vacunador: Primer Refuerzo en Niños y Niñas de 5 a 11 Años - Campaña Nacional de Vacunación contra la COVID-19

Feraud, H. Ministerio de Salud Argentina (2022) C2
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
 Download  (616)
  View PDF  (334)
 Add to my MEDBOX

WHO Guidelines for Malaria- 20 November 2024

World Health Organisation (WHO) (2024) C_WHO
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant than pyrethroids, its bioavailability declines ... more